Method for treating atherosclerosis employing an aP2 inhibitor and combination

Details for Australian Patent Application No. 2003204602 (hide)

Owner Bristol-Myers Squibb Company

Inventors Robi, Jeffrey A; Kodukula, Krishna; Jacobson, Bruce L; Jamil, Haris; Biller, Scott A; Parker, Rex A

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003204602

Parent 755563

Filing date 10 June 2003

Wipo publication date 24 July 2003

International Classifications

A61K 031/50 - Pyridazines

A61K 031/505 - Pyrimidines

A61K 031/42 - Oxazoles

Event Publications

26 June 2003 Complete Application Filed

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2003204602

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204603-Improvements relating to ostomy pouches

2003204601-Adhesive wafer for ostomy pouch